SCHEMBL9049697

SCHEMBL9049697

CCOC(OCC)C1CCCN1C(=O)[C@H]1NCCC1C(=O)CC[C@@H]1CCc2ccccc2C1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PREP P48147 16/20 0.38
UGCG Q16739 1/20 0.32
OPRD1 P41143 1/20 0.31
F2 P00734 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9049692 1.00 PREP (0.38) PREPUGCGOPRD1F2MCHR1
SCHEMBL9049081 0.86 PREP (0.36) PREPUGCGOPRD1F2
SCHEMBL9049636 0.82 PREP (0.34) PREP
SCHEMBL9048554 0.81 PREP (0.52) PREPF2
SCHEMBL9048561 0.81 PREP (0.52) PREPF2
SCHEMBL9050167 0.80 PREP (0.57) PREP
SCHEMBL9049537 0.80 PREP (0.57) PREP
SCHEMBL9048722 0.79 PREP (0.39) PREPF2
SCHEMBL9048636 0.78 PREP (0.41) PREPUGCGMCHR1
SCHEMBL9051862 0.78 PREP (0.41) PREPUGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed